drugset / Trial / NCT06593665
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RandomizedParallel-groupDouble-blindOther
Summary
This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.
Timeline
- Start
- 2024-09-10
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methadone | Other / unclassified | 0.2 mg/kg | Intravenous |
| Subject | Morphine | Other / unclassified | 200 ug | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 7.5 mg | Intrathecal |